Phathom Pharmaceuticals Inc（PHAT）價格預測PHATPhathom Pharmaceuticals Inc

Alphio's PHAT stock price prediction model matches the current Phathom Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.97 (+0.52%). The 1-week path is $5.61 (-5.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Phathom Pharmaceuticals (PHAT) is not a good buy right now due to its current price of $5.74, which is significantly below the average analyst price target of $20-$22. The stock has experienced a 63.46% year-to-date decline and a 17.05% drop over the last five days, indicating a bearish trend. Additionally, the RSI is at a low 19.803, suggesting oversold conditions, but the overall financial performance remains concerning with a gross margin of 79.68% in Q2 2026, while the company still faces challenges with a net income loss of $17.58 million in the same quarter. The primary risk is the ongoing legal challenge against the FDA, which could further impact market confidence.

Phathom Pharmaceuticals Inc (PHAT) last closed at $5.9400001, gaining +3.48%. These facts feed the 1-day and 1-week PHAT price prediction above.